Astria Therapeutics, Inc.
USD12.58
+0.00 (+0.00%)
CEO
Jill C. Milne
IPO Date
2015-06-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$12.58
Prev. Close
$12.58
Day Low
$12.58
Day High
$12.58
52W Low
$3.56
52W High
$13.29
Market Cap
$0.72B
Volume
3.06M
| 8,333 |
| $3.00 |
| 23 Jan 2026 | Violin Jonathan | director | D-Return | Acquired | 14,100 | $9.18 |
| 23 Jan 2026 | Violin Jonathan | director | D-Return | Disposed | 263,321 | $0.00 |
| 23 Jan 2026 | Violin Jonathan | director | D-Return | Acquired | 14,166 | $12.24 |
| 23 Jan 2026 | Violin Jonathan | director | D-Return | Acquired | 26,550 | $5.79 |
| 23 Jan 2026 | Morabito Christopher | Chief Medical Officer | D-Return | Disposed | 80,000 | $3.87 |
| 23 Jan 2026 | Morabito Christopher | Chief Medical Officer | D-Return | Disposed | 262,500 | $6.41 |
| 23 Jan 2026 | Milne Jill C. | director, officer: CEO and President | D-Return | Disposed | 761,000 | $6.41 |
| 23 Jan 2026 | Milne Jill C. | director, officer: CEO and President | D-Return | Disposed | 4,377 | $0.00 |